Medicine Compliance Aid Stability
LampreneNovartis Pharmaceuticals UK Ltd
Novartis Pharmaceuticals UK Ltd
Capsules 50mg, 100mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light. Airtight container. Protect from moisture.
24 April 2015
Lactation Safety Information
Limited published evidence of safety
Significant amounts in breast milk
Pink tint of milk reported
Red coloration of skin and pigmentation reported in breastfed infants
A clinical decision regarding whether a mother with leprosy should breastfeed will need to be made
4 August 2020